Phase I/IIa trials of a novel T-cell epitope-based peptide therapy for peanut allergy

Project: Research

StatusFinished
Effective start/end date1/01/1631/12/18

Funding

  • National Health & Medical Research Council (NHMRC): AUD1,440,000.00